Hydroxamic acid - A novel molecule for anticancer therapy
Hydroxamic acid is a potent moiety not only in the field of cancer therapy but also as a mutagenic agent. Among the various derivatives of hydroxamic acid, SAHA (Suberoylanilide Hydroxamic Acid) is considered as a potent anticancer agent. Scientists from the different corner synthesized different hy...
Saved in:
Main Authors: | Dilipkumar Pal (Author), Supriyo Saha (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Prediction of Binding Affinities of Hybrid Molecules of Benzothiazole cross-linked with Hydroxamic acid by certain linkers
by: yazen alqaysi, et al.
Published: (2024) -
Design, Synthesis, and Biological Evaluation of Novel Hydroxamic Acid-Based Organoselenium Hybrids
by: Jameelah S. Alotaibi, et al.
Published: (2023) -
In Silico Prediction of Binding Affinities of Hybrid Molecules of Benzothiazole Linked with Hydroxamic Acid by Disulfide Bond and Certain Linkers with HDAC8 Enzyme
by: Mayssam Hazem, et al.
Published: (2024) -
Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
by: Joonhyeok Choi, et al.
Published: (2022) -
Design and synthesis of novel hydroxamic acid derivatives based on quisinostat as promising antimalarial agents with improved safety
by: Manjiong Wang, et al.
Published: (2022)